MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

TREMOR AND BRADYKINESIA ARE TWO UNRELATED SIDE EFFECTS INDUCED BY VALPROATE INTAKE

A. de Biase, G. Paparella, L. Angelini, A. Cannavacciuolo, D. Colella, E. Cerulli Irelli, A. Gialllonardo, C. Di Bonaventura, A. Berardelli, M. Bologna (Rome, Italy)

Meeting: 2022 International Congress

Abstract Number: 509

Keywords: Bradykinesia, Cerebellum, Tremors: Clinical features

Category: Drug-Induced Movement Disorders

Objective: To better characterize clinical and neurophysiological features of valproate-induced tremor in patients with epilepsy and the effect of valproate on the execution of voluntary movements.

Background: To date, only a few clinical and neurophysiological studies have investigated the features of valproate-induced tremor.[1],[2] In addition, little is known about how valproate affects voluntary movements.

Method: We tested 29 patients with valproate-induced tremor (13 taking valproate alone and 16 taking valproate plus other antiepileptic drugs). Patients underwent a standardized neurological examination, video recordings, and kinematic assessment of postural, kinetic, and rest upper limb tremor using a motion analysis system. Movement execution was tested by kinematic assessment of repetitive finger tapping. Data of patients with valproate-induced tremor were compared to those of 13 epileptic patients taking valproate but without tremor, 20 patients with Parkinson’s disease, and 20 healthy controls.

Results: Clinical and kinematic evaluation showed that tremor in patients taking valproate alone was less severe than tremor in patients taking valproate plus other antiepileptics [Figure1]. In addition, all patients taking valproate, regardless of the presence of tremor, performed slower finger tapping as compared to healthy controls, similar to what was observed in Parkinson’s disease patients, although with no sequence effect [Figure2].

Conclusion: Tremor and bradykinesia (movement slowness) are motor signs induced valproate intake[3]. The severity of valproate-induced tremor is exacerbated when valproate is taken in combination with other antiepileptics. Valproate-induced bradykinesia occurs regardless of tremor. The appearance of bradykinesia may precede tremor development in patients under valproate.

FIgure1

Figure2

References: [1] Morgan JC, Sethi KD. Drug-induced tremors. Lancet Neurol. 2005;4(12):866-876;
[2] Paparella G, Angelini L, De Biase A, Cannavacciuolo A, Colella D, Di Bonaventura C, Giallonardo AT, Berardelli A, Bologna M. Clinical and Kinematic Features of Valproate-Induced Tremor and Differences with Essential Tremor. Cerebellum. 2021 Jun;20(3):374-383.
[3] Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs. 2002;16(10):695-714;

To cite this abstract in AMA style:

A. de Biase, G. Paparella, L. Angelini, A. Cannavacciuolo, D. Colella, E. Cerulli Irelli, A. Gialllonardo, C. Di Bonaventura, A. Berardelli, M. Bologna. TREMOR AND BRADYKINESIA ARE TWO UNRELATED SIDE EFFECTS INDUCED BY VALPROATE INTAKE [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/tremor-and-bradykinesia-are-two-unrelated-side-effects-induced-by-valproate-intake/. Accessed May 9, 2025.
  • Tweet
  • Email
  • Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/tremor-and-bradykinesia-are-two-unrelated-side-effects-induced-by-valproate-intake/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • The hardest symptoms that bother patients with Parkinson's disease
  • The clinical effects of mucuna and green tea in combination with levodopa-benserazide in advanced Parkinson's disease: Experience from a case report
  • To be or not to bupropion: a drug-induced parkinsonism?
  • #25822 (not found)
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Restless Leg Syndrome After Propranolol Intake: A Single Case
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley